
CASE DISCUSSION
Myth vs. Medicine: Unraveling the Truth About Contrast-Induced AKI & Nephropathy
Views
7,485
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
"Myth vs. Medicine: Unraveling the Truth About Contrast-Induced AKI & Nephropathy" is a focused session aimed at debunking long-held misconceptions surrounding contrast media and kidney injury. Despite widespread concern, recent evidence challenges the traditional belief that contrast agents are a...
Case Summary
- Dr. V's presentation addresses the crucial distinction between contrast-associated acute kidney injury (CA-AKI) and contrast-induced nephropathy (CIN), emphasizing that CA-AKI is a temporal association, while CIN requires a causal link, excluding other potential causes of kidney injury. He highlights the global concern about contrast nephrotoxicity, noting historical overestimation and the resulting unnecessary delays in essential imaging.
Speaker Profile

Dr. Ahmed Sabry
Director of Nephrology, Hayat National Hospitals, Saudi ArabiaDisclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.